447,832 Shares in Merck KGaA $MKGAF Acquired by Tocqueville Asset Management L.P.

Tocqueville Asset Management L.P. acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAF) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 447,832 shares of the company’s stock, valued at approximately $57,546,000. Tocqueville Asset Management L.P. owned approximately 0.35% of Merck KGaA as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Gables Capital Management Inc. bought a new stake in Merck KGaA in the second quarter worth approximately $2,095,000. Diversify Advisory Services LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at $3,810,000. Danske Bank A S bought a new position in shares of Merck KGaA during the 2nd quarter valued at $276,535,000. Danica Pension Livsforsikringsaktieselskab acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at $25,541,000. Finally, BOK Financial Private Wealth Inc. acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at $523,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.

Merck KGaA Trading Up 4.5%

Shares of OTCMKTS:MKGAF opened at $167.38 on Thursday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a market capitalization of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The firm has a fifty day moving average price of $162.50 and a 200 day moving average price of $148.28.

Merck KGaA Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.